UMass Medical School-licensed HIV firm wins FDA approval
A biotechnology company working on a vaccine to prevent HIV, whose work is licensed by UMass Medical School in Worcester, has won U.S. Food and Drug Administration approval to advance its clinical work. The firm, Worcester HIV Vaccine, was approved for the FDA's investigational new drug process for a vaccine that's aimed at preventing the virus that causes AIDS. An early-stage clinical trial is expected to start this month, with a second-phase trial to follow, the medical school said Friday. Image Dr. Shan Lu The potential vaccine is based on discoveries by Dr. Shan Lu, a professor of medicin...